Exploring the utility of ctDNA testing in high-risk breast cancer patients in a community setting: case series

Exploring the utility of ctDNA testing in high-risk breast cancer patients in a community setting: case series

Despite initial treatment, breast cancer recurrence affects approximately 30% of patients. Currently, there exists no standardized approach to detect recurrence before clinical or radiologic signs manifest. Circulating tumor DNA (ctDNA) is a minimally invasive blood test that offers potential to mon...

Full description

Saved in:
Bibliographic Details
Main Authors: Kasen Wong, Alyssa Kameoka, Jami Aya Fukui
Format: Article
Language:English
Published: SAGE Publishing 2025-07-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/17588359251351121
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items